Mahle William T, Vincent Robert N, Kanter Kirk R
Sibley Heart Center Cardiology, Children's Healthcare of Atlanta, GA 30322, USA.
J Thorac Cardiovasc Surg. 2005 Aug;130(2):542-6. doi: 10.1016/j.jtcvs.2005.02.050.
For children in whom graft failure develops after cardiac transplantation, retransplantation is often considered. Although some centers have reported equivalent results for retransplantation as for primary transplantation, this strategy remains controversial. We sought to examine outcomes after retransplantation in children and to identify risk factors for mortality.
United Network for Organ Sharing records of heart transplantation for subjects younger than 18 years from 1987 to 2004 were reviewed. Indications for retransplantation and patient characteristics were evaluated. Analysis was performed with proportional hazards regression, controlling for other potential risk factors.
Among the 4227 pediatric heart transplants, there were 219 retransplants. The most common indication for retransplantation was coronary allograft vasculopathy (51%). The mean interval from initial heart transplant to retransplantation was 4.7 +/- 3.8 years. Forty-two retransplants (19%) were performed within 180 days of primary transplantation. Survivals at 1, 5, and 10 years after retransplantation were 79%, 53%, and 44%, respectively. In multivariate analysis, retransplantation was associated with significantly higher mortality than primary transplantation (odds ratio 1.67, 95% confidence interval 1.32-2.12, P < .001). Patients who underwent retransplantation within 180 days of primary transplantation had a significantly lower 1-year survival than did other retransplant recipients (53% vs 86%, respectively, P < .02). Subjects who required mechanical ventilation before retransplantation also had poorer survival (P < .03).
Survival after cardiac retransplantation in children is inferior to that after primary transplantation. Although results are acceptable, the impact of retransplantation on the availability of donor hearts requires further consideration.
对于心脏移植后发生移植物衰竭的儿童,常考虑进行再次移植。尽管一些中心报告再次移植的结果与初次移植相当,但这一策略仍存在争议。我们试图研究儿童再次移植后的结局,并确定死亡的危险因素。
回顾了1987年至2004年器官共享联合网络中18岁以下心脏移植受者的记录。评估再次移植的指征和患者特征。采用比例风险回归分析,并控制其他潜在危险因素。
在4227例小儿心脏移植中,有219例再次移植。再次移植最常见的指征是冠状动脉移植血管病变(51%)。从初次心脏移植到再次移植的平均间隔时间为4.7±3.8年。42例再次移植(19%)在初次移植后180天内进行。再次移植后1年、5年和10年的生存率分别为79%、53%和44%。多因素分析显示,再次移植与比初次移植显著更高的死亡率相关(优势比1.67,95%置信区间1.32 - 2.12,P <.001)。在初次移植后180天内接受再次移植的患者1年生存率显著低于其他再次移植受者(分别为53%对86%,P <.02)。再次移植前需要机械通气的患者生存率也较差(P <.03)。
儿童心脏再次移植后的生存率低于初次移植。尽管结果尚可,但再次移植对供体心脏可用性的影响需要进一步考虑。